211 related articles for article (PubMed ID: 29943187)
1. Diagnosis of Recurrent Fracture in a Pediatric Cohort.
Fiscaletti M; Coorey CP; Biggin A; Briody J; Little DG; Schindeler A; Munns CF
Calcif Tissue Int; 2018 Nov; 103(5):529-539. PubMed ID: 29943187
[TBL] [Abstract][Full Text] [Related]
2. Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate.
Lindahl K; Kindmark A; Rubin CJ; Malmgren B; Grigelioniene G; Söderhäll S; Ljunggren Ö; Åström E
Bone; 2016 Jun; 87():11-8. PubMed ID: 26957348
[TBL] [Abstract][Full Text] [Related]
3. Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.
Folkestad L
Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619932
[TBL] [Abstract][Full Text] [Related]
4. Differing lumbar vertebral mineralization rates in ambulatory pediatric patients with osteogenesis imperfecta.
Reinus WR; McAlister WH; Schranck F; Chines A; Whyte MP
Calcif Tissue Int; 1998 Jan; 62(1):17-20. PubMed ID: 9405727
[TBL] [Abstract][Full Text] [Related]
5. Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment.
Land C; Rauch F; Travers R; Glorieux FH
Bone; 2007 Mar; 40(3):638-44. PubMed ID: 17127117
[TBL] [Abstract][Full Text] [Related]
6. Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years.
Palomo T; Fassier F; Ouellet J; Sato A; Montpetit K; Glorieux FH; Rauch F
J Bone Miner Res; 2015 Dec; 30(12):2150-7. PubMed ID: 26059976
[TBL] [Abstract][Full Text] [Related]
7. Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement.
Letocha AD; Cintas HL; Troendle JF; Reynolds JC; Cann CE; Chernoff EJ; Hill SC; Gerber LH; Marini JC
J Bone Miner Res; 2005 Jun; 20(6):977-86. PubMed ID: 15883638
[TBL] [Abstract][Full Text] [Related]
8. Bone mass, bone markers and prevalence of fractures in adults with osteogenesis imperfecta.
Wekre LL; Eriksen EF; Falch JA
Arch Osteoporos; 2011; 6(1):31-8. PubMed ID: 22207876
[TBL] [Abstract][Full Text] [Related]
9. Skeletal clinical characteristics of osteogenesis imperfecta caused by haploinsufficiency mutations in COL1A1.
Ben Amor IM; Roughley P; Glorieux FH; Rauch F
J Bone Miner Res; 2013 Sep; 28(9):2001-7. PubMed ID: 23529829
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of quality of life, functional and bone outcomes in osteogenesis imperfecta with bisphosphonate therapy initiated in childhood or adulthood.
Feehan AG; Zacharin MR; Lim AS; Simm PJ
Bone; 2018 Aug; 113():137-143. PubMed ID: 29787832
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up in osteogenesis imperfecta type VI.
Trejo P; Palomo T; Montpetit K; Fassier F; Sato A; Glorieux FH; Rauch F
Osteoporos Int; 2017 Oct; 28(10):2975-2983. PubMed ID: 28689307
[TBL] [Abstract][Full Text] [Related]
12. Imaging in osteogenesis imperfecta: Where we are and where we are going.
Gazzotti S; Sassi R; Aparisi Gómez MP; Moroni A; Brizola E; Miceli M; Bazzocchi A
Eur J Med Genet; 2024 Apr; 68():104926. PubMed ID: 38369057
[TBL] [Abstract][Full Text] [Related]
13. Bone structure assessed by HR-pQCT, TBS and DXL in adult patients with different types of osteogenesis imperfecta.
Kocijan R; Muschitz C; Haschka J; Hans D; Nia A; Geroldinger A; Ardelt M; Wakolbinger R; Resch H
Osteoporos Int; 2015 Oct; 26(10):2431-40. PubMed ID: 25956285
[TBL] [Abstract][Full Text] [Related]
14. Bone densitometry in pediatric patients treated with pamidronate.
Grissom LE; Kecskemethy HH; Bachrach SJ; McKay C; Harcke HT
Pediatr Radiol; 2005 May; 35(5):511-7. PubMed ID: 15655696
[TBL] [Abstract][Full Text] [Related]
15. Novel homozygous variant in BMP1 associated with a rare osteogenesis imperfecta phenotype.
Choksi IN; Cox A; Robinson C; Bale A; Carpenter TO
Osteoporos Int; 2021 Jun; 32(6):1239-1244. PubMed ID: 33624138
[TBL] [Abstract][Full Text] [Related]
16. Bone density, fractures and the associated factors in iranian children and adolescent with Osteogenesis Imperfecta.
Mohsenzade P; Amirhakimi A; Honar N; Saki F; Omrani GHR; Dabbaghmanesh M
BMC Pediatr; 2021 Jan; 21(1):37. PubMed ID: 33446151
[TBL] [Abstract][Full Text] [Related]
17. Association of trabecular bone score and bone mineral apparent density with the severity of bone fragility in children and adolescents with osteogenesis imperfecta: A cross-sectional study.
Ohata Y; Kitaoka T; Ishimi T; Yamada C; Nakano Y; Yamamoto K; Takeyari S; Nakayama H; Fujiwara M; Kubota T; Ozono K
PLoS One; 2023; 18(8):e0290812. PubMed ID: 37643181
[TBL] [Abstract][Full Text] [Related]
18. Cumulative radiation exposure from medical imaging and associated lifetime cancer risk in children with osteogenesis imperfecta.
Thorby-Lister A; Högler W; Hodgson K; Crabtree N; Nightingale P; Shaw N; Saraff V
Bone; 2018 Sep; 114():252-256. PubMed ID: 29960081
[TBL] [Abstract][Full Text] [Related]
19. Fracture Rates and Fracture Sites in Patients With Osteogenesis Imperfecta: A Nationwide Register-Based Cohort Study.
Folkestad L; Hald JD; Ersbøll AK; Gram J; Hermann AP; Langdahl B; Abrahamsen B; Brixen K
J Bone Miner Res; 2017 Jan; 32(1):125-134. PubMed ID: 27448250
[TBL] [Abstract][Full Text] [Related]
20. Reliability of vertebral fractures assessment (VFA) in children with osteogenesis imperfecta.
Diacinti D; Pisani D; D'Avanzo M; Celli M; Zambrano A; Stoppo M; Diacinti D; Roggini M; Todde F; D'Eufemia P; Pepe J; Minisola S
Calcif Tissue Int; 2015 Apr; 96(4):307-12. PubMed ID: 25694358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
